UroGen Pharma Ltd. (URGN) financial statements (2021 and earlier)

Company profile

Business Address 9 HA'TA'ASIYA ST
RA'ANANA, 4365007
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments102120125119147158189
Cash and cash equivalents53253626506690
Short-term investments49958993979299
Restricted cash and investments1111110
Receivables730    
Inventory, net of allowances, customer advances and progress billings211    
Inventory211    
Other undisclosed current assets3422112
Total current assets:116129130122149160191
Noncurrent Assets
Operating lease, right-of-use asset23334  
Property, plant and equipment2211111
Long-term investments and receivables262640496444
Long-term investments262640496444
Restricted cash and investments0000000
Other noncurrent assets00 0023
Total noncurrent assets:6113145546747
TOTAL ASSETS:122140161167202227239
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:108991187
Accounts payable3454532
Accrued liabilities1010111
Employee-related liabilities      4
Other undisclosed accounts payable and accrued liabilities6444650
Debt   221 
Other liabilities2112211
Other undisclosed current liabilities10862544
Total current liabilities:21181614191412
Noncurrent Liabilities
Long-term debt and lease obligation122232 
Operating lease, liability122232 
Liabilities, other than long-term debt3      
Liability for uncertainty in income taxes3      
Other undisclosed noncurrent liabilities (2)(2)   2
Total noncurrent liabilities:4222322
Total liabilities:26191816221614
Stockholders' equity
Stockholders' equity attributable to parent96121143150180211225
Common stock0000000
Additional paid in capital453446439416408400391
Accumulated other comprehensive income0010000
Accumulated deficit(357)(326)(297)(266)(228)(189)(167)
Total stockholders' equity:96121143150180211225
TOTAL LIABILITIES AND EQUITY:122140161167202227239

Income statement (P&L) ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Revenues83000 0
Sublease income0000   
Cost of revenue(1)(0)(0)    
Other undisclosed gross profit    (0)  
Gross profit:7300  0
Operating expenses(35)(32)(32)(39)(40)(23)(24)
Other undisclosed operating loss   (0)   
Operating loss:(27)(29)(32)(39)(40)(23)(24)
Nonoperating income
(Investment Income, Nonoperating)
2      
Other undisclosed loss from continuing operations before equity method investments, income taxes(0)   (0)  
Loss from continuing operations before equity method investments, income taxes:(26)(29)(32)(39)(40)(23)(24)
Other undisclosed income from continuing operations before income taxes    5  
Loss from continuing operations before income taxes:(26)(29)(32)(39)(36)(23)(24)
Other undisclosed loss from continuing operations(3)      
Net loss:(29)(29)(32)(39)(36)(23)(24)
Other undisclosed net income (loss) attributable to parent(2)001(3)11
Net loss available to common stockholders, diluted:(31)(29)(31)(38)(39)(22)(22)

Comprehensive Income ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Net loss:(29)(29)(32)(39)(36)(23)(24)
Other comprehensive income (loss)(0)(0)00(0)00
Comprehensive loss:(29)(29)(31)(39)(36)(23)(23)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(2)001(3)11
Comprehensive loss, net of tax, attributable to parent:(31)(29)(31)(38)(39)(22)(22)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: